Metropolitan Life Insurance Company (MetLife)’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,365
| Closed | -$18.6K | – | 1068 |
|
2024
Q1 | $18.6K | Hold |
1,365
| – | – | ﹤0.01% | 1894 |
|
2023
Q4 | $14.9K | Hold |
1,365
| – | – | ﹤0.01% | 2040 |
|
2023
Q3 | $14.9K | Hold |
1,365
| – | – | ﹤0.01% | 2030 |
|
2023
Q2 | $18.1K | Hold |
1,365
| – | – | ﹤0.01% | 1988 |
|
2023
Q1 | $18.6K | Hold |
1,365
| – | – | ﹤0.01% | 1921 |
|
2022
Q4 | $26.7K | Hold |
1,365
| – | – | ﹤0.01% | 1846 |
|
2022
Q3 | $26K | Hold |
1,365
| – | – | ﹤0.01% | 1877 |
|
2022
Q2 | $28.1K | Hold |
1,365
| – | – | ﹤0.01% | 1862 |
|
2022
Q1 | $43.9K | Sell |
1,365
-4,679
| -77% | -$151K | ﹤0.01% | 1670 |
|
2021
Q4 | $281K | Hold |
6,044
| – | – | ﹤0.01% | 1779 |
|
2021
Q3 | $163K | Sell |
6,044
-610
| -9% | -$16.5K | ﹤0.01% | 2229 |
|
2021
Q2 | $171K | Buy |
6,654
+808
| +14% | +$20.7K | ﹤0.01% | 2267 |
|
2021
Q1 | $200K | Buy |
5,846
+2,439
| +72% | +$83.4K | ﹤0.01% | 2020 |
|
2020
Q4 | $115K | Hold |
3,407
| – | – | ﹤0.01% | 2292 |
|
2020
Q3 | $84.1K | Buy |
+3,407
| New | +$84.1K | ﹤0.01% | 2311 |
|